Torrent Pharmaceuticals Ltd. Financials

NSE BSE

11:04 Jul 30

Torrent Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

3732.80

-35.30 (-0.94%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

3732.80

-35.30 (-0.94%)
11:04 Jul 30

Quality

97/100
High Financial Strength

Valuation

28/100
Expensive Valuation

Technical

64/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	8508.04	9620.15	10727.84	11516.09	11835
Operating Expenses +	6076.77	6778.1	7360.19	7795.1	7986
Raw Material	2368.15	2569	2841.22	3050.82	3061
Increase Decrease in Cost	73.86	166.19	-155.01	-274.92	-205
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1526.45	1677.69	1984.4	2203.37	2258
Miscellaneous Expenses	3769.61	4542.38	5056.84	5876.83	2872
Operating Profit	2431.27	2842.05	3367.65	3720.99	3849
Other Income	196.56	45.14	57.91	23.27	-38
Depreciation	662.16	706.59	808.27	794.93	799
Interest	255.06	333.44	353.56	252.31	233
Profit before tax and exceptio..	1710.61	1847.16	2263.73	2697.02	2779
Exceptional Items	-484.7	0	88.38	-24.21	-24
PBT	1225.91	1847.16	2352.11	2672.81	2803
Provision for Taxation	448.73	601.93	695.73	761.56	753
Net Profit	777.18	1245.23	1656.38	1911.25	2002
NET Profit after MI	777.18	1245.23	1656.38	1911.25	2002
EPS	45.93	36.79	48.94	56.47	59.15
Operating Profit Margin (%)	28.58	29.54	31.39	32.31	32.52
Net Profit Margin (%)	9.13	12.94	15.44	16.6	16.92

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	68.30	68.30	68.30	71.20	71.20
FII	16.10	16.30	16.20	14.50	14.20
MF	5.00	5.00	4.90	3.70	4.40
Others	3.60	3.40	3.40	3.30	2.90

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: